Sign In
Free Newsletter
Merck to cut 88 jobs at Rahway headquarters
Merck will eliminate 88 jobs at its Rahway headquarters as part of a multiyear restructuring and cost-cutting initiative.
Merck completes $6.7B Terns acquisition
Merck completes its $6.7B Terns Pharmaceuticals acquisition, boosting its oncology pipeline with a new leukemia drug ahead of its Keytruda patent expiration.
Sun Pharma to acquire Merck spinoff Organon for $11.75B
The addition by India’s largest pharmaceutical company of the women's health-focused Merck spinoff will expand the buyer's global pharma footprint in that space and specialty medicines.
Merck wins FDA approval for once-daily HIV pill Idvynso
The clearance for Idvynso, which combines doravirine and islatravir for adults with HIV-1, helps expand treatment options for patients.
Merck to acquire Terns Pharmaceuticals in $6.7B oncology deal
Merck's addition of Terns Pharmaceuticals will help expand the buyer's pipeline ahead of the expiration for its Keytruda patent in 2028.
Merck restructures Human Health into 2 units
The pharma will split the division into one for oncology and another for Specialty, Pharma & Infectious Diseases, appointing new executives to support its expanding pipeline.
NJ pharma firms join Trump drug pricing deals
Four Garden State companies are among the latest to strike agreements with the White House to lower prescription costs under the president's policy.
NJ companies make top 10 on Newsweek Most Responsible list
The publication's seventh annual ranking features 20 New Jersey firms among the 600 organizations nationwide that made the cut.
Merck, Bristol Myers Squibb plan NJ layoffs (updated)
Amid broader cost-cutting initiatives, the pharma companies are planning workforce reductions that will affect more than 300 total Garden State employees.
Rahway-based Merck to acquire Cidara in $9.2B deal
The transaction will add breakthrough flu antiviral CD388 to the pharmaceutical giant's pipeline as the company expands beyond Keytruda ahead of a patent loss.
Merck to build $3B manufacturing facility in Virginia
The Rahway-headquartered company said the 400,000-square-foot center is expected to create 500 jobs and will strengthen nation's life sciences sector.
Merck moves to cut $3B, jobs in latest restructuring
Along with its financial results for the second quarter of 2025, the Rahway company revealed plans that aim to save $1.7 million annually by the end of 2027.
